1
00:00:02,520 --> 00:00:07,360
Speaker 1: Bloomberg Audio Studios, podcasts, radio news.

2
00:00:08,560 --> 00:00:12,440
Speaker 2: The Stock Movers Report, your roundup of companies making moves

3
00:00:12,480 --> 00:00:16,320
Speaker 2: in the stock market. Harnessing the power of Bloomberg Data.

4
00:00:16,840 --> 00:00:20,400
Speaker 3: Let's take a look at what's happening in the marketplace

5
00:00:20,600 --> 00:00:23,880
Speaker 3: today on Paul Swiney alongside Alexis Christoffers. We're joined by

6
00:00:23,920 --> 00:00:26,200
Speaker 3: Bloomberg's Billy Lipscholtz. Billy, what are you looking at today?

7
00:00:26,320 --> 00:00:28,560
Speaker 1: I want to start with Intel, the story of the

8
00:00:28,640 --> 00:00:31,240
Speaker 1: day right now, up about twenty five percent, biggest intra

9
00:00:31,320 --> 00:00:35,560
Speaker 1: day jump since nineteen eighty seven. This coming after Nvidia

10
00:00:35,680 --> 00:00:38,960
Speaker 1: unveiling plans to invest five billion dollars in plans to

11
00:00:39,040 --> 00:00:41,920
Speaker 1: co design chips. A big move, Paul, for what has

12
00:00:41,960 --> 00:00:45,600
Speaker 1: been really a company that struggled for the last few years,

13
00:00:45,600 --> 00:00:47,680
Speaker 1: though you do have that big government stake plans to

14
00:00:47,680 --> 00:00:49,479
Speaker 1: take about it a ten percent stake in the company.

15
00:00:49,800 --> 00:00:52,159
Speaker 1: Add onto this, a big rebound for the stock, but

16
00:00:52,240 --> 00:00:55,120
Speaker 1: still kind of looks a bit like an EKG to

17
00:00:55,200 --> 00:00:57,200
Speaker 1: me when you look at where this thing has been

18
00:00:57,240 --> 00:00:59,920
Speaker 1: trading over the last two years.

19
00:01:00,840 --> 00:01:03,920
Speaker 3: Got Novo Nordisk on the move today, I guess it's

20
00:01:04,040 --> 00:01:06,399
Speaker 3: it's we keep going back and forth with these companies

21
00:01:06,440 --> 00:01:08,399
Speaker 3: in their typees drugs or weight loss drugs.

22
00:01:08,400 --> 00:01:10,360
Speaker 1: What's the news there. It's a bit of a two

23
00:01:10,400 --> 00:01:14,240
Speaker 1: horse race. Novo Nordisk ADRs ticker Envo rallying more than

24
00:01:14,280 --> 00:01:17,479
Speaker 1: six percent today. This coming after a study showed that

25
00:01:17,560 --> 00:01:23,039
Speaker 1: its diabetes drug outperformed Eli Lilly's so ozempic. That's the

26
00:01:23,080 --> 00:01:26,440
Speaker 1: Novo drug outperforming Eli Lilly's older drug, Trulyicity, and a

27
00:01:26,520 --> 00:01:30,560
Speaker 1: real world survey of certain US patients this showed that

28
00:01:30,640 --> 00:01:33,600
Speaker 1: Medicare patients who took ozempic were twenty three percent less

29
00:01:33,640 --> 00:01:35,960
Speaker 1: likely to have a heart attack or stroke. So seeing

30
00:01:35,959 --> 00:01:38,800
Speaker 1: some positive news there. One thing to keep an eye on, though,

31
00:01:39,000 --> 00:01:41,520
Speaker 1: Novo Nordisk. Again, while it is up more than six

32
00:01:41,520 --> 00:01:44,600
Speaker 1: percent today biggest jump since August, still down fifty three

33
00:01:44,640 --> 00:01:46,440
Speaker 1: percent in the last twelve months. So these are two

34
00:01:46,440 --> 00:01:50,000
Speaker 1: stocks that really rote a lot of momentum and that

35
00:01:50,040 --> 00:01:51,400
Speaker 1: has fallen pretty flat.

36
00:01:51,520 --> 00:01:54,120
Speaker 3: But I think the next thing in this whole weight

37
00:01:54,160 --> 00:01:57,680
Speaker 3: loss thing is the pill that's going to make it,

38
00:01:57,720 --> 00:02:00,280
Speaker 3: I would think easier for a lot of people to take,

39
00:02:00,320 --> 00:02:04,040
Speaker 3: so that broadens the market, hopefully a lower cost maybe

40
00:02:04,080 --> 00:02:09,000
Speaker 3: eventually to consumers. That could be like the second derivatively

41
00:02:09,120 --> 00:02:10,400
Speaker 3: or second wave of this whole thing.

42
00:02:10,520 --> 00:02:12,519
Speaker 1: Well, and that's been the big issue with these two

43
00:02:12,520 --> 00:02:15,640
Speaker 1: companies is that you saw over the last few years

44
00:02:15,639 --> 00:02:18,880
Speaker 1: so much excitement around ozembic. But as a person who

45
00:02:18,919 --> 00:02:21,880
Speaker 1: covered biotech and healthcare for the first five years of

46
00:02:21,880 --> 00:02:24,200
Speaker 1: my career here at Bloomberg, there's always a question of

47
00:02:24,200 --> 00:02:26,040
Speaker 1: what the next generation is. Who's going to be the

48
00:02:26,720 --> 00:02:29,200
Speaker 1: company that kind of drives that into the pioneer. So

49
00:02:29,200 --> 00:02:31,799
Speaker 1: the big question is, to your point, who and when

50
00:02:32,000 --> 00:02:34,280
Speaker 1: will bring an oral medicine to market?

51
00:02:34,400 --> 00:02:36,400
Speaker 3: Yeah, that's gonna because I mean, you walk around now

52
00:02:36,440 --> 00:02:39,040
Speaker 3: and you see someone who maybe could benefit from this,

53
00:02:39,360 --> 00:02:41,760
Speaker 3: and you wonder why they are not taking And there's

54
00:02:41,840 --> 00:02:44,120
Speaker 3: could be a million reasons, but one of them I

55
00:02:44,160 --> 00:02:46,440
Speaker 3: would think would be just kind of the they don't

56
00:02:46,480 --> 00:02:48,800
Speaker 3: like shocks, maybe the cost is too high and things

57
00:02:48,800 --> 00:02:51,040
Speaker 3: like that. So you said that they continue to move

58
00:02:51,080 --> 00:02:53,480
Speaker 3: that forward. That could be big for a lot more

59
00:02:53,760 --> 00:02:57,000
Speaker 3: people speaking of I don't know, let's go tack about it.

60
00:02:57,040 --> 00:02:57,880
Speaker 3: Because I'm a huge fan.

61
00:02:57,919 --> 00:03:01,240
Speaker 1: As everyone you're a fan, I'm a huge fan. I

62
00:03:01,320 --> 00:03:02,720
Speaker 1: go back and forth. I don't know about you between

63
00:03:02,720 --> 00:03:04,600
Speaker 1: the chicken frieds taking the chicken and dumblings.

64
00:03:04,639 --> 00:03:07,320
Speaker 3: I'm a country country boy breakfast, that's kind of what's

65
00:03:07,360 --> 00:03:09,200
Speaker 3: my go to. I love it, but can I admit

66
00:03:09,280 --> 00:03:11,600
Speaker 3: I've never eaten at Cracker Barrel.

67
00:03:11,639 --> 00:03:12,920
Speaker 1: There's not one in Manhattan.

68
00:03:13,000 --> 00:03:13,639
Speaker 3: That's the challenge.

69
00:03:13,680 --> 00:03:14,800
Speaker 1: Well, why do you leave Manhattan?

70
00:03:14,919 --> 00:03:16,839
Speaker 3: You do love, you do get off the rock.

71
00:03:18,320 --> 00:03:21,440
Speaker 1: But to your boy, Cracker Barrel tickers CVRL under a

72
00:03:21,440 --> 00:03:23,919
Speaker 1: bit of pressure, down just about two percent right now,

73
00:03:23,919 --> 00:03:26,160
Speaker 1: though it is trading at the lowest level since early May.

74
00:03:26,560 --> 00:03:28,720
Speaker 1: Is coming after the company laid out a weaker than

75
00:03:28,800 --> 00:03:33,160
Speaker 1: expected forecast, showing lingering issues related to that logo backlash.

76
00:03:33,240 --> 00:03:37,440
Speaker 1: The company projecting revenue for fiscal twenty twenty six between

77
00:03:37,440 --> 00:03:39,840
Speaker 1: three point three to five billion and three point four

78
00:03:39,880 --> 00:03:42,560
Speaker 1: to five billion. Analysts we're above that with just about

79
00:03:42,560 --> 00:03:45,600
Speaker 1: three and a half billion dollars, so falling short again.

80
00:03:45,680 --> 00:03:48,160
Speaker 1: Big question is how do they kind of deal with

81
00:03:48,160 --> 00:03:51,680
Speaker 1: the fallout from that rebranding, given that we did see

82
00:03:51,720 --> 00:03:55,560
Speaker 1: some data from the same store sales and foot traffic

83
00:03:55,800 --> 00:03:58,000
Speaker 1: showing that there actually was a pretty notable drop.

84
00:03:59,440 --> 00:04:03,640
Speaker 2: The stockmover's report from Bloomberg Radio. Check back with us

85
00:04:03,720 --> 00:04:06,520
Speaker 2: throughout the day for the latest roundup of companies making

86
00:04:06,600 --> 00:04:10,200
Speaker 2: news on Wall Street and for the latest market moving headlines.

87
00:04:10,400 --> 00:04:14,400
Speaker 2: Listen to Bloomberg Radio Live. Catch us on YouTube, Bloomberg

88
00:04:14,440 --> 00:04:17,520
Speaker 2: dot com, and on Applecarplay and Android Auto with the

89
00:04:17,560 --> 00:04:18,919
Speaker 2: Bloomberg Business app.